The risk of post-thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulants
Franco Noventa(University of Padua), Maurizio Ciammaichella(Azienda Ospedaliera San Giovanni Addolorata), Marcello Di Nisio(University of Chieti-Pescara), Paolo Prandoni(University of Padua), Nicola Mumoli(Ospedale di Livorno), Nilo Zanatta(Universidade Federal de Santa Maria), Walter Ageno(University of Padua), Davide Imberti, Adriana Visonà(AULSS 2 Marca Trevigiana), Eugenio Bucherini(Ospedale per gli Infermi)
Cited by 40
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
|Blood|2002|1.9k
Oral Anticoagulant Therapy
|CHEST Journal|2012|1.5k
American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism
|Blood Advances|2020|1.4k
Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
|Gastroenterology|1997|1.4k